Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Cloudflare Inc (NET) Price & Performance

Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.

The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.

Cloudflare (NET) trades at $347.76, down 0.83% on the day but remains near recent highs with strong technical momentum. The company shows impressive revenue growth from $975M in 2022 to $2.17B in 2025, though profitability remains elusive with negative net margins. Recent product launches including Basin data platform and post-quantum certificate authority demonstrate continued innovation, while analyst sentiment remains strongly positive with 71% buy ratings.

While Cloudflare demonstrates robust revenue growth and strategic positioning in cloud security, investors face valuation concerns with P/S of 48.7 and persistent negative profitability. The stock's upside depends on continued enterprise adoption and eventual path to profitability, but high valuation multiples create vulnerability to any growth deceleration. Key risks include competitive pressure and the challenge of converting growth into sustainable earnings.